Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.32%
Changement Mensuel
-5.40%
Evolution sur 6 mois
-25.87%
Changement Annuel
+104.11%
Clôture Précédente
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volume
21
Marchés
Actions des Marchés US
Soins de Santé
GALT
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.18 M
63.29 M
64.06 M
64.47 M
—
Valuation ratios
Enterprise value
146.04 M
66.88 M
70.28 M
121.89 M
262.01 M
521.06 M
Price to earnings ratio
-3.77
-1.7
-1.69
-3.3
-7.18
-13.87
Price to sales ratio
455.96
136.7
-299.01
183.93
124.5
146.11
Price to cash flow ratio
-5.05
-1.92
-2.04
-3.71
-8.7
-16.37
Price to book ratio
-0.54
-0.76
-0.19
-0.31
-0.58
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.39
0.68
1.01
0.48
0.64
2.81
Return on equity %
0.12
0.11
0.08
0.06
0.07
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 203.98
-1 087.31
31.59 K
421.99
190.39
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 490.04
-1 046.98
38.52 K
686.22
371.16
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.13
0.49
0.08
1.43
0.09
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
-0.05
0
0.09
0.15
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.21
0.12
0.1
0.05
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.43
0.24
0.12
0.22
0.18
0.76
Net current asset value per share
0.46
0.28
0.15
0.24
0.2
0.87
Tangible book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Working capital per share
0.05
-0.29
-1.61
0.07
-1.93
-3.75
Book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Nouvelles
Le directeur de Galectin Therapeutics, Marc Rubin, démissionne du conseil d’administration
Galectin Therapeutics director Marc Rubin resigns from board
Le directeur financier de Galectin Therapeutics vend des actions pour 233k€
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Le titre de Galectin Therapeutics chute après les retours de la FDA sur son médicament
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA provides feedback on Galectin’s belapectin development program
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)
Galectin Therapeutics Stock: NAVIGATE Data Validates The Fibrosis Thesis (NASDAQ:GALT)
Belapectin shows promising antifibrotic effects in MASH patients